Hjem › Sigdcelleanemi › District of Columbia
Kliniske studier for Sigdcelleanemi i District of Columbia
10 studier for Sigdcelleanemi søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
RekruttererObservasjonsstudie
Alder 4 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05153967Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's National Hospital (MRD-HCT), Washington D.C.
RekruttererObservasjonsstudie
Alder 3 til 20 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06941389Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
RekruttererFase 2
Alder 4 til 21 · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06635902Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Children's National Health System, Washington D.C.
RekruttererFase 2
Alder 2 til 25 · Alle kjønn · Oppdatert 10. mar. 2026 · NCT03587272Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- Children's National Hospital, Washington D.C.
RekruttererFase 2
Alder 2 til 25 · Alle kjønn · Oppdatert 26. sep. 2025 · NCT06358638Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Rekrutterer
Alder 7 til 16 · Alle kjønn · Oppdatert 13. feb. 2025 · NCT06770010Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Rekrutterer
Alder 8 til 16 · Alle kjønn · Oppdatert 10. jan. 2025 · NCT05099874Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.